Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for Mammalian s phase ribonucleotide reductase.
Level 5 - mechanism / opinion, no new human data
In vitro biochemical study without human subjects (design analogy)
PubMed 19176520 · doi:10.1074/jbc.M809338200
What was done
Recombinant mouse ribonucleotide reductase (RNR) components were tested in vitro to compare the kinetics and mechanisms of thioredoxin 1 (Trx1) and glutaredoxins (Grx1 and a Grx2 C40S mutant) as electron donors across varying glutathione (GSH) concentrations.
What was found
Trx1 and Grx1 demonstrated similar catalytic efficiencies (kcat/Km). In the presence of 4 mm GSH, Grx1 had an apparent Km of 0.18 micromolar, whereas Trx1 showed a higher apparent kcat. Grx activity depended on GSH levels with an apparent Km of 3 mm, and the single-cysteine Grx2 C40S mutant maintained enzymatic activity, demonstrating that glutaredoxin utilizes a GSH-mixed disulfide mechanism in contrast to the dithiol mechanism of thioredoxin.
Why it matters
This clarifies the alternate electron-donor pathways maintaining mammalian ribonucleotide reduction, explaining functional differences from bacterial systems and identifying how glutaredoxins can support RNR activity during DNA repair or in thioredoxin-deficient tumor cells.
Limits
Findings rely entirely on recombinant mouse proteins in cell-free assays. The abstract reports no validation in intact cell models, physiological contexts, or human tissues.
Cited by
- supports NADPH is utilized by cells to direct electrons to form carbon-carbon bonds and convert ribonucleotides into deoxyribonucleotides.